Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication
TORONTO, Oct. 23, 2025 ( GLOBE NEWSWIRE ) -- Quantum BioPharma Ltd. ( NASDAQ: QNTM ) ( CSE: QNTM ) ( FRA: 0K91 ) ( Upstream: QNTM ) ( "Quantum BioPharma" ) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging ...
How this was made

The 30-second read
Why it matters
The webinar and innovation announcement could boost investor confidence and stock valuation.
Market read
The news is relevant to biotech and wellness sectors, with potential short-term trading implications for QNTM.
What to watch
Regulatory hurdles or delays in product development could offset optimistic expectations.
Background
Quantum BioPharma is advancing in biotech solutions, with recent licensing agreements and innovation initiatives.
Ticker impact
Quantum BioPharma's recent announcement about its licensee Unbuzzd Wellness hosting a webinar on a disruptive beverage innovation.
Moderate upward movement in QNTM stock over the short term.
The announcement signals potential growth in biotech assets, but the direct impact on stock price depends on market reception and subsequent developments.
Market effects
Potential positive impact on biotech and wellness sectors due to innovation focus.
Limited regional impact; primarily relevant to North American markets.
Moderate, as biotech innovations can influence global health and wellness markets.
Counterpoint
Market may have already priced in the positive outlook; potential for short-term profit-taking leading to a price correction.
Key entities
- CompanyQuantum BioPharma Ltd.
A biopharmaceutical company focusing on innovative biotech assets.
- LicenseeUnbuzzd Wellness
A company hosting a webinar on beverage innovation.




